CGMP for Blood and Blood Components: 3rd Party Disclosures

Current Good Manufacturing Practices for Blood and Related Regulations for and Blood Components; and Requirements for Donor Testing, Donor Notification, and "Lookback"

OMB: 0910-0116

IC ID: 215607

Documents and Forms
Information Collection (IC) Details

View Information Collection (IC)

CGMP for Blood and Blood Components: 3rd Party Disclosures CBER
 
No Modified
 
Mandatory
 
21 CFR 606 21 CFR 630 21 CFR 640 21 CFR 610

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Agency Guidance CBER Bacterial Risk Control Strategies for Platelets forTransfusion DEC 2018.pdf No   Paper Only

Health Consumer Health and Safety

 

7,264 0
   
Private Sector Businesses or other for-profits
 
   100 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 510,030 0 0 0 0 510,030
Annual IC Time Burden (Hours) 57,702 0 0 1 0 57,701
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy